Aminoglycoside adaptive resistance: Importance for effective dosage regimens

Drugs

Volumn 61, Issue 6, 2001, Pages 713-721

  Barclay, M L ^a   Begg, E J ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; DOSE CALCULATION; DOWN REGULATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SENSITIVITY; DRUG TRANSPORT; GENE MUTATION; GRAM NEGATIVE BACTERIUM; HUMAN; META ANALYSIS; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA; REVIEW;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0034980469     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200161060-00001     Document Type: Review

References (26)

1. Once-daily aminoglycoside therapy: Is it less toxic than multiple daily doses and how should it be monitored?
2. Adaptive resistance following single doses of gentamicin in a dynamic in vitro model
3. Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation
4. In vitro characterisation of aminoglycoside adaptive resistance in Pseudomonas aeruginosa
5. Antimicrobial agent therapy for Pseudomonas aeruginosa
6. Concentration-dependent bacterial killing, adaptive resistance and post-antibiotic effect of ciprofloxacin alone and in combination with gentamicin
7. Ionic binding, adaptive resistance and post-antibiotic effect of netilmicin and ciprofloxacin
8. Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: Transient resistance to quinolones and protein F-deficiency
9. Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa
10. Intravenous gentamicin therapy for infections in patients with cancer
11. Pseudomonas bacteremia: Pharmacologic and other bases for failure of treatment with gentamicin
12. The effect of rifampicin on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides
13. The effect of aminoglycoside-induced adaptive resistance on the antibacterial activity of other antibiotics against Pseudomonas aeruginosa in vitro
14. First-exposure adaptive resistance to aminoglycosides in vivo with meaning for optimal clinical use
15. Adaptive resistance of Pseudomonas aeruginosa and killing kinetics in a rabbit endocarditis model
16. Adaptive resistance to tobramycin in Pseudomonas aeruginosa in the sputum of patients with cystic fibrosis
17. Gentamicin accumulation by sensitive strains of Escherichia coli and Pseudomonas aeruginosa
18. Aminoglycoside uptake and mode of action - With special reference to streptomycin and gentamicin. I. Antagonists and mutants. II. Effects of aminoglycosides on cells
19. Antibiotic uptake into Gram-negative bacteria
20. The inductive role of ionic binding in the bactericidal and postexposure effects of aminoglycoside antibiotics with implications for dosing
21. Aminoglycosides
22. Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa
23. Roles of ribosomal binding, membrane potential and electron transport in bacterial uptake of streptomycin and gentamicin
24. Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: A model for entry of streptomycin and gentamicin in susceptible and resistant bacteria
25. Altered denA and anr gene expression in aminoglycoside adaptive resistance in Pseudomonas aeruginosa